1. P006 Host-genetics, dysbiosis, and clinical history explains fecal metabolic alterations in patients with Inflammatory Bowel Disease. (27th May 2021) Authors: Vich Vila, A; Hu, S; Andreu-Sánchez, S; Collij, V; Jansen, D; Ruigrok, R; Abu-Ali, G; Parkinson, J; Al Garawi, A; Schneider, J; Kurilshikov, A; Björk, J; Gacesa, R; Fu, J; Zhernakova, A; Weersma, R K Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The putative tumour modifier gene ATP5A1 is not mutated in human colorectal cancer cell lines but expression levels correlate with TP53 mutations and chromosomal instability. Issue 7 (3rd March 2009) Authors: Seth, R; Keeley, J; Abu-Ali, G; Crook, S; Jackson, D; Ilyas, M Journal: Journal of clinical pathology Issue: Volume 62:Issue 7(2009) Page Start: 598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗